Related Experiment Videos
Whole blood white cell aggregation: a novel technique.
J J Belch1, A R Saniabadi, C D Forbes
1University Department of Medicine, Royal Infirmary, Glasgow, United Kingdom.
Thrombosis Research
|December 15, 1987
Summary
Elevated white blood cell counts are linked to ischemic events. Researchers developed a new whole blood assay to measure white cell aggregation, crucial for understanding vascular diseases.
Area of Science:
- Hematology
- Cardiovascular Research
- Vascular Biology
Background:
- Epidemiological studies link elevated white blood cell (WBC) counts to ischemic events.
- WBCs share functional similarities with platelets, including adhesion, aggregation, and release reactions.
- Understanding WBC aggregation is critical in the context of vascular diseases.
Purpose of the Study:
- To investigate white cell aggregation in vascular diseases.
- To develop and describe a novel method for measuring whole blood white cell aggregation.
- To evaluate the effect of Iloprost on white cell aggregation.
Main Methods:
- Development of a new technique to measure whole blood white cell aggregation.
- Utilized specific aggregating agents to stimulate WBC aggregation.
- Investigated the impact of Iloprost, a synthetic prostacyclin analogue, on WBC aggregation.
Main Results:
- A novel method for assessing whole blood white cell aggregation was successfully developed.
- The study characterized the aggregation patterns of white cells in response to various agents.
- Iloprost demonstrated an effect on white cell aggregation, suggesting potential therapeutic implications.
Conclusions:
- The developed method provides a new tool for studying white cell aggregation in vascular disease research.
- White cell aggregation plays a role in vascular pathologies.
- Iloprost may modulate white cell aggregation, warranting further investigation for its therapeutic potential in vascular conditions.